Arastéh K - Search Results

1

Predictors of treatment failure during highly active antiretroviral therapy (racing trial).

Masuhr A, Mueller M, Simon V, Zwingers T, Kurowski M, Jessen H, Lauenroth-Mai E, Moll A, Schranz D, Moecklinghoff C, Arastéh K. Masuhr A, et al. Among authors: arasteh k. Eur J Med Res. 2002 Aug 30;7(8):341-6. Eur J Med Res. 2002. PMID: 12204841 Clinical Trial.

2

Arastéh KN, Cordes C, Ewers M, Simon V, Dietz E, Futh UM, Brockmeyer NH, L'age MP. Arastéh KN, et al. Eur J Med Res. 2000 Oct 30;5(10):424-30. Eur J Med Res. 2000. PMID: 11076783

3

Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients.

Marretta L, Stocker H, Drauz D, Mueller M, Masuhr A, Dieckmann S, Wong V, Koch A, Grueneisen A, Arastéh K, Weiss R. Marretta L, et al. Among authors: arasteh k. Eur J Med Res. 2011 May 12;16(5):197-205. doi: 10.1186/2047-783x-16-5-197. Eur J Med Res. 2011. PMID: 21719392 Free PMC article.

4

[Opportunistic diseases in AIDS].

Arastéh K, Simon V. Arastéh K, et al. Pflege Aktuell. 1997 Dec;51(12):741-5. Pflege Aktuell. 1997. PMID: 9456794 German. No abstract available.

5

Sensitivity and specificity of indirect immunofluorescence and Grocott-technique in comparison with immunocytology (alkaline phosphatase anti alkaline phosphatase = APAAP) for the diagnosis of Pneumocystis carinii in broncho-alveolar lavage (BAL).

Arastéh KN, Simon V, Musch R, Weiss RO, Przytarski K, Futh UM, Pleuger F, Huhn D, L'age MP. Arastéh KN, et al. Eur J Med Res. 1998 Dec 16;3(12):559-63. Eur J Med Res. 1998. PMID: 9889176

6

Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration.

Stocker H, Herzmann C, Breske A, Kruse G, Berger M, Schulbin H, Hill A, Steinmüller J, Becker M, Arastéh K, Kurowski M. Stocker H, et al. Among authors: arasteh k. J Antimicrob Chemother. 2007 Mar;59(3):560-4. doi: 10.1093/jac/dkl516. Epub 2007 Jan 25. J Antimicrob Chemother. 2007. PMID: 17255144

7

Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients.

Stocker H, Kruse G, Kreckel P, Herzmann C, Arastéh K, Claus J, Jessen H, Cordes C, Hintsche B, Schlote F, Schneider L, Kurowski M. Stocker H, et al. Among authors: arasteh k. Antimicrob Agents Chemother. 2004 Nov;48(11):4148-53. doi: 10.1128/AAC.48.11.4148-4153.2004. Antimicrob Agents Chemother. 2004. PMID: 15504834 Free PMC article. Clinical Trial.

8

Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings.

Stocker H, Kloft C, Plock N, Breske A, Kruse G, Herzmann C, Schulbin H, Kreckel P, Weber C, Goebel F, Roeling J, Staszewski S, Plettenberg A, Moecklinghoff C, Arastéh K, Kurowski M. Stocker H, et al. Among authors: arasteh k. Antimicrob Agents Chemother. 2006 Feb;50(2):667-73. doi: 10.1128/AAC.50.2.667-673.2006. Antimicrob Agents Chemother. 2006. PMID: 16436725 Free PMC article.

9

Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors.

Arastéh K, Stocker H. Arastéh K, et al. Eur J Med Res. 2007 Oct 15;12(9):397-402. Eur J Med Res. 2007. PMID: 17933720 Review.

10

Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT).

Arasteh K, Weitner L, Fenske S, Kuhlmann B, Freiwald M, Ebrahimi R, Gallo L, Ranneberg R, Mertenskoetter T. Arasteh K, et al. Eur J Med Res. 2009 May 14;14(5):195-9. doi: 10.1186/2047-783x-14-5-195. Eur J Med Res. 2009. PMID: 19541575 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page